World Wildlife Day is celebrated on March 3 each year since 2014 to raise awareness about endangered flora and fauna. Delicate ecological…
admin
-
-
WORLD WILDLIFE DAY 2022: Animals and plants have a huge contribution to our ecological system. They also contribute to the generic, social, economic,…
-
Lupin PharmaRegulatoryU.S FDA
Lupin launches Sevelamer Hydrochloride tablets in the United States used in treatment of kidney disease
by adminby adminHighligts : Sevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagel Tablets, 800 mg of Genzyme Corporation used in the…
-
Global MarketMerger / Acquisition
SeQuent Scientific acquires Brazil-based animal drug firm for $5 million
by adminby adminSummary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr),…
-
Synopsis : Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager…
-
Merger / Acquisition
bdr: BDR looking to buy majority stake in drug plant in Belarus
by adminby adminSummary : BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year from Renuka Ramnath-led private equity (PE) fund…
-
Summary : Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the…
-
RegulatoryU.S FDA
J&J, Legend Introduce New CAR-T Therapy to Multiple Myeloma Market
by adminby adminSummary : Johnson & Johnson’s partner, Legend Biotech, has been awarded U.S. Food and Drug Administration approval for its chimeric antigen receptor…
-
GileadRegulatoryU.S FDA
FDA Rejects Gilead’s Long-Acting HIV Drug Over Vial Issues
by adminby adminSummary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
-
AbbVieCompaniesMerger / Acquisition
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
by adminby adminSummary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…
